Christophe Bardin

2.7k total citations
45 papers, 2.0k citations indexed

About

Christophe Bardin is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christophe Bardin has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christophe Bardin's work include Safe Handling of Antineoplastic Drugs (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (5 papers). Christophe Bardin is often cited by papers focused on Safe Handling of Antineoplastic Drugs (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Pharmaceutical studies and practices (5 papers). Christophe Bardin collaborates with scholars based in France, Netherlands and United Kingdom. Christophe Bardin's co-authors include Irving M. Spitz, A. Astier, Lauri Benton, Angélo Paci, Étienne Chatelut, Gareth J. Veal, Nicolas Widmer, Dominique Levêque, Jos H. Beijnen and Jean‐Marc Tréluyer and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Infectious Diseases.

In The Last Decade

Christophe Bardin

43 papers receiving 1.9k citations

Peers

Countries citing papers authored by Christophe Bardin

Since Specialization

Citations

This map shows the geographic impact of Christophe Bardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Bardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Bardin more than expected).

Fields of papers citing papers by Christophe Bardin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Bardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Bardin. The network helps show where Christophe Bardin may publish in the future.

Co-authorship network of co-authors of Christophe Bardin

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Bardin. A scholar is included among the top collaborators of Christophe Bardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Bardin. Christophe Bardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO) 2025 ·Annales Pharmaceutiques Françaises ·Florence Ranchon, Florian Slimano, Isabelle Borget, (unknown), Christophe Bardin, (unknown), (unknown), (unknown), Raphaëlle Fanciullino, Muriel Paul, Florent Puisset, Catherine Rioufol, (unknown), Jean‐François Tournamille, Jean Vigneron, (unknown), Bertrand Pourroy, (unknown)	0
2	Clinical oncology pharmacy has become a reality: results of a member survey of the European Society of Oncology Pharmacy Global 2024 ·(unknown), Christophe Bardin, Maja Kuzmanović, (unknown), (unknown), Mirjam Crul	1
3	Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines) 2020 ·Cancer Treatment Reviews ·Florian Slimano, (unknown), Jérémie Zerbit, (unknown), Audrey Thomas‐Schoemann, (unknown), Mikaël Daouphars, Isabelle Madelaine, Bertrand Pourroy, Jean‐François Tournamille, A. Astier, Florence Ranchon, (unknown), Christophe Bardin, Catherine Rioufol	33
4	Review of therapeutic drug monitoring of anticancer drugs part two – Targeted therapies 2014 ·European Journal of Cancer ·Nicolas Widmer, Christophe Bardin, Étienne Chatelut, Angélo Paci, Jos H. Beijnen, Dominique Levêque, Gareth J. Veal, A. Astier	240
5	Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics 2014 ·European Journal of Cancer ·Angélo Paci, Gareth J. Veal, Christophe Bardin, Dominique Levêque, Nicolas Widmer, Jos H. Beijnen, A. Astier, Étienne Chatelut	210
6	Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach 2014 ·Clinical Pharmacokinetics ·Célia Lloret‐Linares, Déborah Hirt, Christophe Bardin, Jean‐Luc Bouillot, Jean‐Michel Oppert, Christine Poitou, François Chast, Stéphane Mouly, Jean‐Michel Scherrmann, Jean‐François Bergmann, Xavier Declèves	52
7	Therapeutic drug monitoring in cancer – Are we missing a trick? 2014 ·European Journal of Cancer ·Christophe Bardin, Gareth J. Veal, Angélo Paci, Étienne Chatelut, A. Astier, Dominique Levêque, Nicolas Widmer, Jos H. Beijnen	76
8	The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing 2013 ·Osteoporosis International ·Jeshmi Jeyabalan, Benoı̂t Viollet, Peter Smitham, Stanley Ellis, Gul Zaman, Christophe Bardin, Allen E. Goodship, Jean‐Paul Roux, (unknown), Chantal Chenu	77
9	Drug interactions with solid tumour-targeted therapies 2013 ·Critical Reviews in Oncology/Hematology ·Audrey Thomas‐Schoemann, Benoı̂t Blanchet, Christophe Bardin, Gaëlle Noé, Pascaline Boudou‐Rouquette, Michel Vidal, François Goldwasser	74
10	Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus 2012 ·European Journal of Clinical Pharmacology ·Christophe Bardin, Estelle Nobécourt, Étienne Larger, François Chast, Jean‐Marc Tréluyer, Saı̈k Urien	32
11	A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) 2010 ·Annals of the Rheumatic Diseases ·Pierre Quartier, Florence Allantaz, Rolando Cimaz, Pascal Pillet, Claude Messiaen, Christophe Bardin, Xavier Bossuyt, Anne Boutten, Jacques Bienvenu, A. Duquesne, Olivier Richer, Damien Chaussabel, A. Mogenet, Jacques Banchereau, Jean‐Marc Tréluyer, Paul Landais, Virginia Pascual	381
12	Pharmacology of Morphine in Obese Patients 2009 ·Clinical Pharmacokinetics ·Célia Lloret Linares, Xavier Declèves, Jean Michel Oppert, Arnaud Basdevant, Karine Clément, Christophe Bardin, J M Scherrmann, J.P. Lépine, Jean‐François Bergmann, Stéphane Mouly	46
13	Apports de l’informatique à la prescription, à l’évaluation et à la sécurité du circuit des médicaments anticancéreux 2005 ·Bulletin de l Académie Nationale de Médecine ·François Chast, (unknown), Christophe Bardin	4
14	Préparation d’un collyre de ciclosporine à 2 % 2004 ·Journal Français d Ophtalmologie ·F. Chast, François Lemare, (unknown), Rui Batista, Christophe Bardin, G Renard	13
15	Dosage plasmatique des énantiomères de la méthadone par chromatographie liquide à haute performance 2004 ·Annales Pharmaceutiques Françaises ·Rui Batista, (unknown), Christophe Bardin, F. Chast	2
16	Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis 2000 ·Clinical Microbiology and Infection ·Christophe Piketty, Christophe Bardin, Jacques Gilquin, A. Gairard, M Kazatchkine, F. Chast	30
17	Impact of ASCO guidelines for the use of hematopoietic colony stimulating factors (CSFs): survey results of fifteen Paris university hospitals. 1999 ·Pharmacy World & Science ·Isabelle Debrix, Isabelle Madelaine, (unknown), Dominique Roux, Christophe Bardin, Franck Mercier, Jean Fontan, (unknown), (unknown), P. Tilleul	2
18	Low Plasma Concentrations Achieved with Conventional Schedules of Administration of Ganciclovir in Patients with AIDS 1996 ·The Journal of Infectious Diseases ·Christophe Piketty, Christophe Bardin, Jacques Gilquin, Vincent Mahé, M Kazatchkine, F. Chast	19
19	CEFTAZIDIME : AVANTAGES DES PERFUSIONS CONTINUES CHEZ UN MALADE EN APLASIE 1993 ·La Presse Médicale ·O. Legrand, (unknown), Christophe Bardin, Yvonnick Bézie, (unknown), (unknown), F. Chast, R Zittoun	2
20	Biovailability of fluoride in postmenopausal women: Comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate 1992 ·Calcified Tissue International ·Frédéric Lioté, Christophe Bardin, Amélie Liou, (unknown), (unknown), Daniel Kuntz	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact